FI964815A0 - Piperatsiinijohdoksia 5-HT1A antagonisteina - Google Patents

Piperatsiinijohdoksia 5-HT1A antagonisteina

Info

Publication number
FI964815A0
FI964815A0 FI964815A FI964815A FI964815A0 FI 964815 A0 FI964815 A0 FI 964815A0 FI 964815 A FI964815 A FI 964815A FI 964815 A FI964815 A FI 964815A FI 964815 A0 FI964815 A0 FI 964815A0
Authority
FI
Finland
Prior art keywords
piperazine derivatives
ht1a antagonists
hydrogen
compounds
ht1a
Prior art date
Application number
FI964815A
Other languages
English (en)
Swedish (sv)
Other versions
FI114985B (fi
FI964815A (fi
Inventor
Christopher Ian Brightwell
Michael Gerard Kelly
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of FI964815A0 publication Critical patent/FI964815A0/fi
Publication of FI964815A publication Critical patent/FI964815A/fi
Application granted granted Critical
Publication of FI114985B publication Critical patent/FI114985B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
FI964815A 1994-06-03 1996-12-02 Piperatsiinijohdoksia 5-HT1A antagonisteina FI114985B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9411099 1994-06-03
GB9411099A GB9411099D0 (en) 1994-06-03 1994-06-03 Piperazine derivatives
GB9501263 1995-01-23
PCT/GB1995/001263 WO1995033743A1 (en) 1994-06-03 1995-06-01 Piperazine derivatives as 5ht1a antagonists

Publications (3)

Publication Number Publication Date
FI964815A0 true FI964815A0 (fi) 1996-12-02
FI964815A FI964815A (fi) 1996-12-02
FI114985B FI114985B (fi) 2005-02-15

Family

ID=10756114

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964815A FI114985B (fi) 1994-06-03 1996-12-02 Piperatsiinijohdoksia 5-HT1A antagonisteina

Country Status (25)

Country Link
US (1) US5723464A (fi)
EP (1) EP0763031B1 (fi)
JP (1) JPH10500989A (fi)
KR (1) KR100359393B1 (fi)
CN (2) CN1048985C (fi)
AT (1) ATE192744T1 (fi)
AU (1) AU680147B2 (fi)
BR (1) BR9507910A (fi)
CA (1) CA2191871C (fi)
CZ (1) CZ287381B6 (fi)
DE (1) DE69516867T2 (fi)
DK (1) DK0763031T3 (fi)
ES (1) ES2145275T3 (fi)
FI (1) FI114985B (fi)
GB (1) GB9411099D0 (fi)
GR (1) GR3033449T3 (fi)
HU (1) HUT76466A (fi)
IL (1) IL113967A (fi)
MX (1) MX9605915A (fi)
NZ (2) NZ287498A (fi)
PT (1) PT763031E (fi)
RU (1) RU2165933C2 (fi)
SK (1) SK281418B6 (fi)
WO (1) WO1995033743A1 (fi)
ZA (1) ZA954525B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
WO1995033725A1 (en) * 1994-06-03 1995-12-14 John Wyeth & Brother Limited Novel processes and intermediates for the preparation of piperazine derivatives
JP3155008B2 (ja) * 1994-07-26 2001-04-09 ファイザー・インコーポレーテッド セロトニンアゴニストおよびアンタゴニストとしての４−インドール誘導体
US5486518A (en) * 1995-04-10 1996-01-23 American Home Products Corporation 4-indolylpiperazinyl derivatives
US5519025A (en) * 1995-04-10 1996-05-21 American Home Products Corporation 4-indolylpiperazinyl derivatives
IT1282705B1 (it) * 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE19725664A1 (de) * 1997-06-18 1998-12-24 Merck Patent Gmbh 3-Benzylpiperidine
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
AU9256498A (en) * 1997-08-01 1999-02-22 Recordati S.A. Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
EP1087954A1 (en) * 1998-06-15 2001-04-04 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
WO2002070482A1 (fr) * 2001-02-27 2002-09-12 Kaneka Corporation Procede de production de derives de n-aryl-1-amino-2-propanol optiquement actifs
JP4391241B2 (ja) * 2002-03-12 2009-12-24 ワイス キラルｎ−アリールピペラジンの合成方法
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
AU2003220122A1 (en) * 2002-03-12 2003-09-29 Wyeth Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
CA2477906A1 (en) 2002-03-12 2003-09-25 Ivo Jirkovsky Process for making chiral 1,4-disubstituted piperazines
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
CN100436448C (zh) * 2003-06-11 2008-11-26 惠氏公司 二环吲哚基衍生物以及其作为5-羟色胺能活性剂的应用
US7179813B2 (en) * 2003-06-11 2007-02-20 Wyeth Bicyclic indolyl derivatives and methods for their use as serotonergic agents
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
CA2649576A1 (en) * 2006-06-09 2007-12-21 Wyeth Method for enhancing cognitive function
EP3151820A4 (en) 2014-06-06 2017-11-22 Flexus Biosciences, Inc. Immunoregulatory agents
US11242319B2 (en) 2014-11-05 2022-02-08 Flexus Biosciences, Inc. Immunoregulatory agents
AR102537A1 (es) 2014-11-05 2017-03-08 Flexus Biosciences Inc Agentes inmunomoduladores
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
DE69033100T2 (de) * 1989-04-22 2000-01-05 Wyeth John & Brother Ltd Piperazin-Derivate
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
IL113967A (en) 1999-03-12
FI114985B (fi) 2005-02-15
SK281418B6 (sk) 2001-03-12
DK0763031T3 (da) 2000-08-14
CN1093122C (zh) 2002-10-23
ATE192744T1 (de) 2000-05-15
DE69516867T2 (de) 2000-11-02
PT763031E (pt) 2000-10-31
NZ331452A (en) 2000-01-28
KR100359393B1 (ko) 2003-01-24
IL113967A0 (en) 1995-10-31
NZ287498A (en) 1998-10-28
GB9411099D0 (en) 1994-07-27
AU680147B2 (en) 1997-07-17
CN1227841A (zh) 1999-09-08
DE69516867D1 (de) 2000-06-15
GR3033449T3 (en) 2000-09-29
HUT76466A (en) 1997-09-29
BR9507910A (pt) 1997-08-12
MX9605915A (es) 1997-12-31
ZA954525B (en) 1996-12-02
SK154196A3 (en) 1997-08-06
FI964815A (fi) 1996-12-02
CZ287381B6 (en) 2000-11-15
CZ350796A3 (en) 1997-06-11
HU9603315D0 (en) 1997-01-28
JPH10500989A (ja) 1998-01-27
WO1995033743A1 (en) 1995-12-14
US5723464A (en) 1998-03-03
KR970703333A (ko) 1997-07-03
EP0763031A1 (en) 1997-03-19
CA2191871A1 (en) 1995-12-14
ES2145275T3 (es) 2000-07-01
RU2165933C2 (ru) 2001-04-27
EP0763031B1 (en) 2000-05-10
AU2623095A (en) 1996-01-04
CA2191871C (en) 2004-09-21
CN1149873A (zh) 1997-05-14
CN1048985C (zh) 2000-02-02

Similar Documents

Publication Publication Date Title
FI964815A0 (fi) Piperatsiinijohdoksia 5-HT1A antagonisteina
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
AP2002002637A0 (en) Novel piperazine
CO5271691A1 (es) Nuevos compuestos
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
JO2321B1 (en) 4-phenyl-pyridine derivatives
NO20001514L (no) Vitronectin-reseptor-antagonist
MX9800483A (es) Derivados de piperazina y su uso como antagonistas de 5-ht1a.
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
DE3477664D1 (en) 2-(n-pyrrolidino)-3-isobutoxy-n-phenyl-substituted n-benzylpropyl amines, their preparation and their pharmaceutical use
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
ES2148745T3 (es) Derivados de piperidina usados como diureticos.
EA200100156A2 (ru) Новые производные 6-сульфамоил-3-хинолилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции
IL160266A0 (en) Hydroxamic acid derivatives

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114985

Country of ref document: FI